The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Randhawa Simrat since 2023.
This trader's CIK number is 1992260.
At the time of last reporting, Randhawa Simrat was the EVP, Head of R&D of Dianthus Therapeutics, Inc. /de/. (stock ticker symbol DNTH).
Also see all insider trading activities at Dianthus Therapeutics, Inc. /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DNTH | 0 | $0 | 196,538 | $7,383,337 | 196,538 | $3,394,686 |
| 2023 | DNTH | 4,000 | $52,800 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-13 | DNTH | Option Ex | 87,507 | 13.16 | 1,151,592 |
| 2025-11-14 | DNTH | Sale | 109,031 | 38.14 | 4,158,442 |
| 2025-11-13 | DNTH | Sale | 87,507 | 36.85 | 3,224,895 |
| 2025-11-14 | DNTH | Option Ex | 109,031 | 20.57 | 2,243,094 |
| 2023-09-22 | DNTH | Buy | 2,000 | 13.20 | 26,400 |
| 2023-09-21 | DNTH | Buy | 2,000 | 13.20 | 26,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Randhawa Simrat (EVP, Head of R&D of Dianthus Therapeutics, Inc. /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.